January 20, 2022
Life Sciences
  • A new analysis by the Congressional Budget Office found that savings from generics have driven average prescription prices down in Medicare and Medicaid. Between 2018 and 2019, the average price for a generic prescription fell in both program while the use jumped from 75 percent to 90 percent of all prescriptions nationally. However, net prices of brand-name drugs more than doubled in Part D and increased by 50 percent in Medicaid, per the analysis. These increases were driven by higher launch prices for new drugs and price increases for drugs already on the market. (Report here)